Literature DB >> 29555393

Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial.

A Fuchs1, V Gotta1, M-L Decker1, G Szinnai2, P Baumann3, J Bonhoeffer3, N Ritz4.   

Abstract

OBJECTIVES: Standard inflammatory markers and chest radiography lack the ability to discriminate bacterial from non-bacterial lower respiratory tract infection (LRTI). Cytokine profiles may serve as biomarkers for LRTI, but their applicability to identify aetiology, severity of disease and need for antibiotic prescription in children remains poorly defined. Objectives were to determine the cytokine kinetic profiles over 5 days in paediatric patients with LRTI, to investigate the relationship between cytokine patterns, and clinical and laboratory variables.
METHODS: We included patients aged 1 month to 18 years, with febrile LRTI and three consecutive cytokines measurements on days 1, 3 and 5 of a randomized controlled trial (ProPAED study). We evaluated differences in cytokine concentrations between days and associations with clinical and laboratory variables.
RESULTS: A total of 181 patients (median age 4.1 years) were included; 72/181 (40%) received antibiotics. Serum concentrations of interferon (IFN)-γ, interleukin (IL)-1ra, IL-6, IL-10, IFN-γ-inducible protein (IP)-10 and tumor necrosis factor-α were elevated on day 1 and decreased subsequently, with the greatest decline between day 1 and 3 (by -8 to >-94%). Procalcitonin (PCT) and C-reactive protein (CRP) values showed a protracted decrease with the most prominent reduction in concentrations between days 3 and 5. Significantly elevated IL-6 concentrations were associated with hospital admission, antibiotic treatment, and prolonged antibiotic treatment. Bacteraemic LRTI patients had higher concentrations of IL-1ra (p <0.0055) and IL-6 (p <0.0055) on day 1.
CONCLUSIONS: We observed an earlier decrease of elevated cytokines compared to PCT or CRP. Both pro- and anti-inflammatory cytokines may serve as markers for severity of LRTI.
Copyright © 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial agents; Immune system; bacterial infections; cytokines; paediatrics

Mesh:

Substances:

Year:  2018        PMID: 29555393     DOI: 10.1016/j.cmi.2018.03.016

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

Review 1.  Biomarkers in Cystic Fibrosis Lung Disease - A Review.

Authors:  Ioana Mihaiela Ciuca; Paula Marian; Marc Monica
Journal:  Rom J Anaesth Intensive Care       Date:  2020-10-11

2.  Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children.

Authors:  Yanpeng Li; Xuemin Fu; Jinmin Ma; Jianhui Zhang; Yihong Hu; Wei Dong; Zhenzhou Wan; Qiongfang Li; Yi-Qun Kuang; Ke Lan; Xia Jin; Jian-Hua Wang; Chiyu Zhang
Journal:  Nat Commun       Date:  2019-05-23       Impact factor: 14.919

Review 3.  Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group.

Authors:  Dina Goodman; Mary E Crocker; Farhan Pervaiz; Eric D McCollum; Kyle Steenland; Suzanne M Simkovich; Catherine H Miele; Laura L Hammitt; Phabiola Herrera; Heather J Zar; Harry Campbell; Claudio F Lanata; John P McCracken; Lisa M Thompson; Ghislaine Rosa; Miles A Kirby; Sarada Garg; Gurusamy Thangavel; Vijayalakshmi Thanasekaraan; Kalpana Balakrishnan; Carina King; Thomas Clasen; William Checkley
Journal:  Lancet Respir Med       Date:  2019-10-04       Impact factor: 30.700

4.  Immune Response against Adenovirus in Acute Upper Respiratory Tract Infections in Immunocompetent Children.

Authors:  Giovanni Battista Biserni; Arianna Dondi; Riccardo Masetti; Jessica Bandini; Ada Dormi; Francesca Conti; Andrea Pession; Marcello Lanari
Journal:  Vaccines (Basel)       Date:  2020-10-13

5.  Prediction of disease severity in young children presenting with acute febrile illness in resource-limited settings: a protocol for a prospective observational study.

Authors:  Sakib Burza; Yoel Lubell; Arjun Chandna; Endashaw M Aderie; Riris Ahmad; Eggi Arguni; Elizabeth A Ashley; Tanya Cope; Vu Quoc Dat; Nicholas P J Day; Arjen M Dondorp; Victor Illanes; Joanne De Jesus; Carolina Jimenez; Kevin Kain; Keang Suy; Constantinos Koshiaris; Estrella Lasry; Mayfong Mayxay; Dinesh Mondal; Rafael Perera; Tiengkham Pongvongsa; Sayaphet Rattanavong; Michael Rekart; Melissa Richard-Greenblatt; Mohammad Shomik; Phouthalavanh Souvannasing; Veronica Tallo; Claudia Turner; Paul Turner; Naomi Waithira; James A Watson; Mikhael Yosia
Journal:  BMJ Open       Date:  2021-01-25       Impact factor: 2.692

6.  Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children.

Authors:  Yang Li; Lanfang Min; Xin Zhang
Journal:  BMC Pulm Med       Date:  2021-11-26       Impact factor: 3.317

7.  Increased Cytokine Levels Assist in the Diagnosis of Respiratory Bacterial Infections or Concurrent Bacteremia in Patients With Non-Hodgkin's Lymphoma.

Authors:  Lihua Zhang; Jinping Zhang; Haiping He; Xiaosui Ling; Fan Li; Zefeng Yang; Jinlian Zhao; Huiyuan Li; Tonghua Yang; Shixiang Zhao; Keqian Shi; Xin Guan; Renbin Zhao; Zengzheng Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-08       Impact factor: 6.073

Review 8.  Potential Diagnostic and Prognostic Biomarkers for Adenovirus Respiratory Infection in Children and Young Adults.

Authors:  Giovanni Battista Biserni; Sara Scarpini; Arianna Dondi; Carlotta Biagi; Luca Pierantoni; Riccardo Masetti; Sugitha Sureshkumar; Alessandro Rocca; Marcello Lanari
Journal:  Viruses       Date:  2021-09-21       Impact factor: 5.048

9.  The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections.

Authors:  Philipp Baumann; Aline Fuchs; Verena Gotta; Nicole Ritz; Gurli Baer; Jessica M Bonhoeffer; Michael Buettcher; Ulrich Heininger; Gabor Szinnai; Jan Bonhoeffer
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

10.  Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case-control study.

Authors:  Elena María Rincón-López; María Luisa Navarro Gómez; Teresa Hernández-Sampelayo Matos; David Aguilera-Alonso; Eva Dueñas Moreno; Jesús Saavedra-Lozano; Begoña Santiago García; María Del Mar Santos Sebastián; Marina García Morín; Cristina Beléndez Bieler; Jorge Lorente Romero; Elena Cela de Julián
Journal:  BMC Infect Dis       Date:  2021-08-03       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.